Thermo Fisher Scientific Inc Market Cap ($224.59 Billion)
Market Cap & Net Worth: Thermo Fisher Scientific Inc (TMO)
Thermo Fisher Scientific Inc market cap. Thermo Fisher Scientific Inc (NYSE:TMO) has a market capitalization of $224.59 Billion ($224.59 Billion) as of November 4, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #87 globally and #57 in its home market, demonstrating a 1.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Thermo Fisher Scientific Inc's stock price $682.65 by its total outstanding shares 375708059 (375.71 Million). Also see Thermo Fisher Scientific Inc (TMO) cash conversion ratio for how efficiently the company converts equity into cash flow.
Thermo Fisher Scientific Inc Market Cap History (2015–2026)
Thermo Fisher Scientific Inc market cap history from 2015 to 2026. Data shows growth from $52.01 Billion to $256.48 Billion (16.55% CAGR). Check TMO share price today for real-time trading data and today's change.
Index Memberships
Thermo Fisher Scientific Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.43 Trillion | 0.37% | #46 of 503 |
|
S&P 100
OEX
|
$44.08 Trillion | 0.52% | #41 of 101 |
Weight: Thermo Fisher Scientific Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Thermo Fisher Scientific Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Thermo Fisher Scientific Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore TMO net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.56x
Thermo Fisher Scientific Inc's market cap is 4.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
30.85x
Thermo Fisher Scientific Inc's market cap is 30.85 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $52.01 Billion | $16.97 Billion | $1.98 Billion | 3.07x | 26.33x |
| 2016 | $51.95 Billion | $18.27 Billion | $2.02 Billion | 2.84x | 25.69x |
| 2017 | $70.15 Billion | $20.92 Billion | $2.23 Billion | 3.35x | 31.53x |
| 2018 | $82.92 Billion | $24.36 Billion | $2.94 Billion | 3.40x | 28.22x |
| 2019 | $120.69 Billion | $25.54 Billion | $3.70 Billion | 4.73x | 32.65x |
| 2020 | $173.45 Billion | $32.22 Billion | $6.38 Billion | 5.38x | 27.21x |
| 2021 | $248.98 Billion | $39.21 Billion | $7.72 Billion | 6.35x | 32.23x |
| 2022 | $205.94 Billion | $44.91 Billion | $6.95 Billion | 4.59x | 29.63x |
| 2023 | $199.03 Billion | $42.86 Billion | $6.00 Billion | 4.64x | 33.20x |
| 2024 | $195.45 Billion | $42.88 Billion | $6.33 Billion | 4.56x | 30.85x |
Competitor Companies of TMO by Market Capitalization
Companies near Thermo Fisher Scientific Inc in the global market cap rankings as of November 4, 2026. Also see Thermo Fisher Scientific Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Thermo Fisher Scientific Inc by market ranking:
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $161.03 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #493 globally with a market cap of $54.62 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #539 globally with a market cap of $50.18 Billion USD ( CN¥342.92 Billion CNY).
- Agilent Technologies Inc (NYSE:A): Ranked #616 globally with a market cap of $43.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #143 | Danaher Corporation | NYSE:DHR | $161.03 Billion | $227.97 |
| #493 | Natera Inc | NASDAQ:NTRA | $54.62 Billion | $378.92 |
| #539 | WuXi AppTec Co Ltd | SHG:603259 | $50.18 Billion | CN¥138.65 |
| #616 | Agilent Technologies Inc | NYSE:A | $43.76 Billion | $171.99 |
Market Capitalization of Thermo Fisher Scientific Inc (2015–2026)
Market capitalization of Thermo Fisher Scientific Inc from 2015 to today. Between 2015 and today, Thermo Fisher Scientific Inc's market cap moved from $52.01 Billion to $ 256.48 Billion, with a yearly change of 16.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $256.48 Billion | +17.81% |
| 2025 | $217.70 Billion | +11.38% |
| 2024 | $195.45 Billion | -1.80% |
| 2023 | $199.03 Billion | -3.36% |
| 2022 | $205.94 Billion | -17.29% |
| 2021 | $248.98 Billion | +43.54% |
| 2020 | $173.45 Billion | +43.72% |
| 2019 | $120.69 Billion | +45.55% |
| 2018 | $82.92 Billion | +18.21% |
| 2017 | $70.15 Billion | +35.03% |
| 2016 | $51.95 Billion | -0.12% |
| 2015 | $52.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Thermo Fisher Scientific Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $224.59 Billion USD |
| MoneyControl | $224.59 Billion USD |
| MarketWatch | $224.59 Billion USD |
| marketcap.company | $224.59 Billion USD |
| Reuters | $224.59 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more